drugset / Trial / NCT00715039
Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder
RandomizedParallel-groupTriple-blindBasic science
Summary
The study is to assess the performance characteristics of a new measure to assess onset of efficacy in a GAD patient population.
Timeline
- Start
- 2003-10
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lorazepam | Small molecule | 1.5 mg | Oral |
| Comparator | Paroxetine | Small molecule | 20 mg | Oral |